The synthetic estrogen 4-estren-3α,17β-diol (estren) induces estrogen-like neuroprotection

• Main Authors: Myriam Cordey, Usha Gundimeda, Rayudu Gopalakrishna, Christian J. Pike
• Format: Article
• Language: English
• Published: Elsevier 2005-06-01
• Series: Neurobiology of Disease
• Subjects: 4-Estren-3α, 17β-Diol; Estren; Estrogen; 17β-Estradiol; 17α-Estradiol; β-Amyloid
• Online Access: http://www.sciencedirect.com/science/article/pii/S0969996105000264

Estrogen has demonstrated neuroprotective properties, which may underlie the observed preventive effect of estrogen-based hormone therapy (HT) against the development of neurodegenerative disorders such as Alzheimer's disease. Deleterious side effects of HT have increased efforts to develop safer compounds that selectively reproduce beneficial estrogen actions. Recently, 4-estren-3α,17β-diol (estren) was identified as having estrogen agonist properties in bone, without significantly stimulating growth of reproductive tissues. Here, we examined whether estren parallels the neuroprotective actions of estrogen against β-amyloid (Aβ) in cultured cerebrocortical neurons. Estren increased neuronal viability to a similar extent to that observed with 17β-estradiol (E2) and 17α-estradiol. As we previously reported for E2, estren rapidly increased PKC activity, and PKC inhibition prevented estren neuroprotection. In contrast, the estrogen receptor antagonist ICI 182,780 blocked E2, but not estren neuroprotection. Our results indicate that estren-induced activation of rapid cell signaling pathways protects cultured neurons from Aβ toxicity.